Approximately 30,000–40,000 people die from liver disease each year, according to the American Liver Foundation.
“Although the artificial liver is not yet cleared for use on humans, these findings show promise as an effective treatment option for diseases like liver cancer and hepatitis, which is becoming an increasingly common diagnosis.”
For people who experience acute liver failure, the only proven treatment has been liver transplantation. Researchers at Mayo Clinic have developed and are testing an alternative to liver transplantation called the Spheroid Reservoir Bioartificial Liver that can support healing and regeneration of the injured liver, and improve outcomes and reduce mortality rates for patients with acute liver failure — without requiring a transplant.
Developed by Scott Nyberg, M.D., Ph.D., principal investigator in the Artificial Liver and Liver Transplantation Laboratory at Mayo Clinic and liver transplant surgeon, the device uses healthy hepatocytes, or liver cells, from pigs to do the job of a normal, healthy liver, which aids in digestion and the removal of waste and toxins from the bloodstream. Treatment with the Spheroid Reservoir Bioartificial Liver (SRBAL) has been shown to reduce the severity of liver disease and improve survival in pigs. Future clinical studies are planned to assess the SRBAL as a less-invasive, long-term treatment option to liver transplantation. Results from a study using the device in a pivotal preclinical trial were published today in the Journal of Hepatology.
“Acute liver failure claims the lives of over 30 percent of people who are diagnosed with this condition. Liver transplantation has been the go-to option for treating acute liver failure, but it also comes with many risks and isn’t always an option, due to compatibility and availability of donor livers,” says Dr. Nyberg. “A bioartificial liver device could allow physicians to treat and extend the lives of more patients, safely and cost-effectively, with fewer risks.”
The study conducted by Dr. Nyberg was designed to serve as a preclinical trial on pigs with drug-induced acute liver failure. The animals were treated using the Spheroid Reservoir Bioartificial Liver and were injected with healthy donor hepatocytes to determine if this treatment method could reverse the severity of their disease.
“This study demonstrated that animals treated using the bioartificial liver responded to the healthy hepatocytes and reached the study endpoint with less disease severity than animals that received other forms of treatment,” said Dr. Nyberg. “Although the artificial liver is not yet cleared for use on humans, these findings show promise as an effective treatment option for diseases like liver cancer and hepatitis, which is becoming an increasingly common diagnosis.”
Read more: Researchers Test Bioartificial Liver Device to Treat Acute Liver Failure
The Latest on: Bioartificial Liver
[google_news title=”” keyword=”Bioartificial Liver” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Bioartificial Liver
- Liver Disease Newson May 16, 2024 at 5:00 pm
Apr. 15, 2024 — Innovative carbon beads reduce bad bacteria and inflammation in animal models, which are linked to liver cirrhosis and other serious health ... Overeating and Starving Both ...
- What causes bile duct obstruction?on May 9, 2024 at 4:59 pm
A bile duct obstruction is when one of the ducts that carry bile from the liver to the intestine becomes blocked. Symptoms may include nausea and vomiting, loss of appetite, and abdominal pain.
- What Are High ALT Levels and How to Lower Themon April 25, 2024 at 5:00 pm
A liver enzyme known as ALT plays an important role in breaking down proteins in the digestive process. High levels of ALT in the blood can indicate liver issues. Implementing these strategies may ...
- Food in sight? The liver is ready!on April 24, 2024 at 5:00 pm
A team of researchers has now been able to show in mice that adaptations in the liver mitochondria take place after only a few minutes. Stimulated by the activation of a group of nerve cells in ...
- What is the relation between fish and fatty liver disease?on April 24, 2024 at 3:30 pm
Metabolic Dysfunction-associated Steatotic Liver Disease caused by various factors, where dietary strategies and fish consumption play key roles in preventing fat accumulation. Proper fish ...
- Ochre Bio announces partnership with Boehringer Ingelheim to develop novel regenerative treatments for patients with advanced liver diseaseon April 21, 2024 at 9:00 pm
Boehringer Ingelheim aims to develop new treatments modulating innovative regenerative targets with the potential to enhance the liver’s self-repair capabilities to prevent or reverse disease ...
- Boehringer Ingelheim, Ochre Bio Launch Up-to-$1B+ Liver Disease Partnershipon April 21, 2024 at 5:00 pm
“Ochre Bio brings to the table unique and exciting capabilities in liver disease research,” Søren Tullin, PhD, senior VP and global head of cardiometabolic diseases research, Boehringer ...
- Boehringer Ingelheim Strikes Regenerative Med R&D Deal Spanning MASH & More Liver Diseaseson April 21, 2024 at 5:00 pm
The liver is the only organ in the human body capable of regenerating itself. Boehringer Ingelheim has begun a research alliance with a startup to see if its technology can produce new therapies ...
- Signs of an unhealthy liver: How to recognize symptoms and seek diagnosison April 20, 2024 at 7:14 am
The liver, the largest and most complex organ in the human body, holds significance that goes beyond its size. As an essential part of bodily functions, this vital organ performs critical functions.
- World Liver Day 2024: Date, history, significance and everything that you need to knowon April 19, 2024 at 2:25 am
World Liver Day 2024: From history to theme, here's all that you need to know about the special day. World Liver Day 2024: The liver is an integral part of the body. Situated under the rib cage on ...
via Bing News